BACKGROUND Children with cardiomyopathy (CM) are at risk of sudden cardiac death (SCD), but the incidence and risk
incidence and risk factors for SCD in children with varying CM phenotypes have not previously been well defined (4) (5) (6) (7) . Better data regarding the incidence and risk factors for SCD in this population are required to deploy appropriate primary prevention strategies targeting high-risk individuals.
The NACCS (National Australian Childhood Cardiomyopathy Study) is a population-based cohort study comprising all Australian children under the age of 10 years who were diagnosed with CM over a 10-year period (8) . Using this cohort, we sought to describe the incidence of SCD in young children with different CM phenotypes and to explore risk factors for SCD in this population.
METHODS STUDY DESIGN.
The NACCS is an ongoing cohort study that includes all children in Australia with primary CM who were diagnosed between January 1, 1987, and December 31, 1996, and were younger than 10 years of age at diagnosis. The exclusion criteria included congenital heart disease, arrhythmiainduced cardiac dysfunction, Kawasaki disease, prior exposure to corticosteroids or anthracyclines, progressive systemic, metabolic, or neuromuscular disease resulting in other severe organ involvement, and maternal diabetes or prematurity for children who were diagnosed before 4 weeks of age. Full details of the methods, including enrollment and inclusion and exclusion criteria, have been detailed elsewhere (8) . Local ethics committee approval was obtained in accordance with requirements from each participating center.
DATA COLLECTION. Prospective follow-up was arranged for enrolled study patients, using standardized data collection sheets to document uniform clinical and echocardiographic data at baseline and throughout follow-up. Echocardiographic measurements were normalized according to body surface area or age (9) . The variables recorded for each patient are listed in the Online Appendix. Table 1) . SCD accounted for 15% of all deaths in the study cohort and 24% of deaths among patients who died >1 year after diagnosis.
The cumulative incidence of SCD at 15 years after diagnosis (Central Illustration) was 5% (95% CI: 2% to 11%) for DCM, 6% (95% CI: 2% to 17%) for HCM, 23% Table 2) .
A higher LVEDD Z-score was also associated with DILATED CM. Children with DCM make up the largest proportion of this cohort (59.5%) and have a lower incidence of SCD than children with other CM phenotypes. Late normalization of LV function has been noted in a high proportion of children with DCM (13) and may account for the generally lower rates of SCD in this CM phenotype.
In the current study, familial CM was an important risk factor for SCD in patients with DCM, a phenomenon that could potentially be explained by the presence of familial proarrhythmic genotypes (14, 15) . This finding is in contrast to a report from the PCMR (Pediatric Cardiomyopathy Registry), in which family history was not associated with SCD (16) . In the PCMR study, sex, ethnicity, and etiology were also not associated with SCD, as in our study, and greater LV dilation, age at diagnosis <14.3 years, and lower LV posterior wall thickness to LVEDD ratio were predictive of SCD. The difference with respect to familial DCM between these 2 studies may be explained by the age difference of enrolled patients, the more severe presentation of familial DCM in our younger patients, and our exclusion criteria. In the NACCS registry, familial DCM was also associated with a higher risk of death or transplantation during follow-up (13) .
In children with DCM, the highest risk of death or transplantation occurs in the first year after diagnosis shown that severely increased LV wall thickness is an important marker of risk for SCD (25) (26) (27) . In our study, the most important risk factor for SCD in patients with HCM was the magnitude of LV free wall hypertrophy. The potential protective effect of familial HCM in our cohort of pediatric patients may explain why isolated septal hypertrophy, typically associated Congestive heart failure at diagnosis * Abbreviations as in Tables 1 and 2 . LV NONCOMPACTION. Other than the diagnosis itself, we were unable to identify individual risk factors for SCD in patients with LVNC. This disease is uncommon and has multiple subtypes; the small number of patients in our study may have limited our ability to quantify and detect risk factors for SCD.
These patients have a variable, but generally poor, outcome overall, as has also been noted by other researchers (33, 34) . In a large study of 240 patients with LVNC (34), the risk of SCD was found to be 6%, compared with 23% in the present study. The unexpectedly high incidence of SCD in patients with LVNC may reflect the early onset of severe DCM physiology in our study. Children with LVNC have a high incidence of arrhythmias, and in the presence of ventricular dysfunction, they should be considered at risk of SCD (34) .
RESTRICTIVE CM. We were unable to explore risk factors for SCD in RCM due to the small number of events in this population-based study; however, as suggested here and in previous studies, children with RCM have poor survival rates (35) (36) (37) . In a reported series of 18 children with RCM, 5 (28%) experienced "sudden death events"; 1 of these children was successfully resuscitated and proceeded to transplant and 4 died (38) . Our figures are in accord with this; although the absolute number of patients was small, the incidence rate of death was large. A high proportion of our patients with RCM underwent transplant; because there is no effective therapy for RCM, transplantation is the only therapeutic option that decreases mortality (39) . 
